Llwytho...
Systemic targeted therapy for her2-positive early female breast cancer: a systematic review of the evidence for the 2014 Cancer Care Ontario systemic therapy guideline
BACKGROUND: This systematic review addresses the question “What is the optimal targeted therapy for female patients with early-stage human epidermal growth factor receptor 2 (her2)–positive breast cancer?” METHODS: The medline and embase databases were searched for the period January 2008 to May 201...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | Curr Oncol |
|---|---|
| Prif Awduron: | , , , , , , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
Multimed Inc.
2015
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4381787/ https://ncbi.nlm.nih.gov/pubmed/25848335 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3747/co.22.2322 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|